Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody.
Saavedra D, Añé-Kourí AL, Gregorich EML, Mena J, Lorenzo-Luaces P, Londres HD, Martínez AH, Armada JJ, Sánchez YH, González YZ, Troche M, Medel L, Ramos M, Crombet T. Saavedra D, et al. Among authors: armada jj. Immunol Lett. 2022 Dec;251-252:1-8. doi: 10.1016/j.imlet.2022.09.005. Epub 2022 Sep 27. Immunol Lett. 2022. PMID: 36174772 Free PMC article.
Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment.
Londres HD, Armada JJ, Martínez AH, Abdo Cuza AA, Sánchez YH, Rodríguez AG, Figueroa SS, Llanez Gregorich EM, Torres Lahera ML, Peire FG, González TM, González YZ, Añé Kouri AL, Palomo AG, Concepción MT, Pérez LM, Luaces-Alvarez PL, Iglesias DE, Hernández DS, Suzarte MR, Ramos TC. Londres HD, et al. Among authors: armada jj. Immunotherapy. 2022 May;14(7):521-530. doi: 10.2217/imt-2022-0027. Epub 2022 Mar 21. Immunotherapy. 2022. PMID: 35306855 Free PMC article. Clinical Trial.